Feb 3, 2026 04:38PM
Jan 12, 2026 04:02PM
Dec 30, 2025 08:18AM
Dec 1, 2025 08:32AM
Nov 20, 2025 06:45AM
Nov 17, 2025 07:55AM
Oct 30, 2025 09:25AM N2OFF completes merger with cancer drug discovery firm MitoCareX
Oct 24, 2025 07:55AM
Oct 23, 2025 04:04PM
Oct 23, 2025 08:58AM
Oct 23, 2025 08:26AM
Oct 20, 2025 07:42AM
Oct 15, 2025 07:05AM
Oct 6, 2025 06:41AM SciSparc terminates merger deal with AutoMax Motors
Sep 29, 2025 04:03PM
Sep 25, 2025 04:01PM
Sep 25, 2025 07:05AM
Aug 28, 2025 09:24AM
Aug 28, 2025 06:53AM
Aug 7, 2025 07:32AM
Jul 30, 2025 04:36PM SciSparc merger registration statement declared effective by SEC
Jul 30, 2025 08:21AM
Jul 22, 2025 09:08AM
Jun 24, 2025 05:03PM
May 27, 2025 07:32AM
Apr 25, 2025 08:00AM
Mar 10, 2025 07:27AM
Mar 3, 2025 08:25AM SciSparc (SPRC) to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers
Feb 27, 2025 08:45AM
Feb 26, 2025 09:29AM
Feb 18, 2025 07:17AM
Jan 15, 2025 07:34AM
Jan 13, 2025 08:41AM
Jan 6, 2025 08:15AM
Jan 6, 2025 07:50AM SciSparc (SPRC) and Clearmind (CNMD) Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
Dec 31, 2024 09:27AM
Dec 26, 2024 06:47AM
Dec 16, 2024 07:43AM
Sep 30, 2024 09:25AM
Sep 26, 2024 09:06AM
Sep 23, 2024 08:17AM
Sep 18, 2024 04:09PM SciSparc (SPRC) Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment
Sep 16, 2024 04:06PM
Sep 11, 2024 07:40AM
Sep 6, 2024 07:56AM
Aug 29, 2024 04:26PM
Aug 28, 2024 08:55AM
Aug 22, 2024 08:16AM
Aug 19, 2024 04:11PM SciSparc (SPRC) Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment
Aug 14, 2024 04:54PM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All